Skin cancers in Madagascar: where do we stand?

被引:0
|
作者
Malalaniaina, Andrianarison [1 ]
Lovasoa, Tika [2 ]
Mamisoa, Ranaivo Irina [3 ]
Malala, Razakanaivo [2 ]
Soavina, Ramarozatovo Lala [4 ]
Florine, Rafaramino [2 ]
Fahafahantsoa, Rapelanoro Rabenja [1 ]
机构
[1] Ctr Hosp Univ Joseph Raseta Befelatanana, Serv Dermatol, Antananarivo, Madagascar
[2] Ctr Hosp Univ Joseph Raseta Befelatanana, Serv Oncol, Antananarivo, Madagascar
[3] Ctr Hosp Univ Morafeno, Serv Dermatol, Tamatave, Madagascar
[4] Ctr Hosp Unversitaire Joseph Raseta Befelata, Serv Med Interne & Dermatol, Antananarivo, Madagascar
来源
关键词
Skin cancers; carcinomas; epidemiology; melanoma; Madagascar; MELANOMA; DERMATOLOGY;
D O I
10.11604/pamj.2019.34.167.19269
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: skin cancers are malignant keratinizing tumors of epidermal, melaninic or adnexal origin. These cancers are still little known. However they affect people living in Madagascar where the amount of sunshine remains very high with an impact that varies depending on the skin type. The purpose of our study was to determine the epidemio-clinical profile of skin cancers in Antananarivo. Methods: we conducted a retrospective descriptive study of skin cancers in the Department of Oncology of the Joseph Ravoahangy Andrianavalona Hospital, Antananarivo over a period of seven years. It included patients with tumoral skin lesions confirmed by histological examination. Results: we collected data from 47 cases of skin cancers (male predominance; sex ratio 1.13). The average age of patients was 49.3 years. Farmers were the most affected. The lesions mainly occurred in the head, neck (44%) and lower limbs (42%). Localized skin cancers were detected in 61.7% of cases. Squamous cell carcinoma was the most common skin cancer in Madagascar (37%), followed by the melanoma (21%) and the basal cell carcinoma (11%). Treatment was mainly based on surgery (74.19%). Conclusion: squamous cell carcinoma is the most common cancer in Madagascar, followed by melanoma and basal cell carcinoma. Skin cancers affect mainly the young population and require appropriate management.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] ColVI myopathies: where do we stand, where do we go?
    Valérie Allamand
    Laura Briñas
    Pascale Richard
    Tanya Stojkovic
    Susana Quijano-Roy
    Gisèle Bonne
    Skeletal Muscle, 1
  • [22] ColVI myopathies: where do we stand, where do we go?
    Allamand, Valerie
    Brinas, Laura
    Richard, Pascale
    Stojkovic, Tanya
    Quijano-Roy, Susana
    Bonne, Gisele
    SKELETAL MUSCLE, 2011, 1
  • [23] Investigative dermatology: where do we stand and where do we go?
    Maurer, M.
    von Stebut, E.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (10) : 857 - 857
  • [24] Rye and health - Where do we stand and where do we go?
    Jonsson, Karin
    Andersson, Roger
    Knudsen, Knud Erik Bach
    Hallmans, Goran
    Hanhineva, Kati
    Katina, Kati
    Kolehmainen, Marjukka
    Kyro, Cecilie
    Langton, Maud
    Nordlund, Emilia
    Laerke, Helle Nygaard
    Olsen, Anja
    Poutanen, Kajsa
    Tjonneland, Anne
    Landberg, Rikard
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2018, 79 : 78 - 87
  • [25] Where do we stand in the OECD?
    Buske, L
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1997, 156 (03) : 464 - 464
  • [26] Where do we stand with hepatoblastoma?
    Schnater, JM
    Köhler, SE
    Lamers, WH
    von Schweinitz, D
    Aronson, DC
    CANCER, 2003, 98 (04) : 668 - 678
  • [27] Inflation: Where do we stand?
    Martin, J
    INTERNATIONAL JOURNAL OF MODERN PHYSICS A, 2005, 20 (19): : 4676 - 4682
  • [28] GFIS - Where do we stand?
    Anon
    IUFRO News, 2002, 31 (02):
  • [29] The GSEs: Where do we stand?
    Poole, William
    FEDERAL RESERVE BANK OF ST LOUIS REVIEW, 2007, 89 (03): : 143 - 151
  • [30] VITILIGO - WHERE DO WE STAND
    ORTONNE, JP
    BOSE, SK
    PIGMENT CELL RESEARCH, 1993, 6 (02): : 61 - 72